Literature DB >> 26818542

Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.

Hee Yeon Kim1, Chang Wook Kim, Chung-Hwa Park, Jong Young Choi, Kyungdo Han, Anwar T Merchant, Yong-Moon Park.   

Abstract

BACKGROUND: Sarcopenia and non-alcoholic fatty liver disease (NAFLD) share similar pathophysiological mechanisms, and the relationship between sarcopenia and NAFLD has been recently investigated. The study investigated whether low skeletal muscle mass is differentially associated with NAFLD by gender in Korean adults.
METHODS: We conducted a cross-sectional analysis of the data from the Fifth Korea National Health and Nutrition Examination Survey. The skeletal muscle index (SMI) was obtained by the appendicular skeletal muscle mass divided by the weight. NAFLD was defined as a fatty liver index (FLI) ≥60 in the absence of other chronic liver disease.
RESULTS: Among the included subjects, 18.3% (SE: 1.4%) in men and 7.0% (SE: 0.7%) in women were classified as having FLI-defined NAFLD. Most of the risk factors for FLI-defined NAFLD showed a significant negative correlation with the SMI in both genders. Multiple logistic regression analysis showed that low SMI was associated with FLI-defined NAFLD, independent of other metabolic and lifestyle parameters in both genders [males: odds ratio (OR)=1.35; 95% confidence interval (CI): 1.17-1.54; females: OR=1.36; 95% CI: 1.18-1.55]. The magnitude of the association between FLI-defined NAFLD and low SMI was higher in middle aged to elderly males (OR=1.50; 95% CI: 1.22-1.84) than in males less than 45 years of age (OR=1.25; 95% CI: 1.02-1.52) and in premenopausal females (OR=1.50; 95% CI: 1.12-2.03) than in postmenopausal females (OR=1.36; 95% CI: 1.20-1.54).
CONCLUSIONS: Low SMI is associated with the risk of FLI-defined NAFLD independent of other well-known metabolic risk factors in both genders. This association may differ according to age group or menopausal status. Further studies are warranted to confirm this relationship.

Entities:  

Mesh:

Year:  2016        PMID: 26818542     DOI: 10.1016/s1499-3872(15)60030-3

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  22 in total

Review 1.  Sarcopenia and fatty liver disease.

Authors:  Jung A Kim; Kyung Mook Choi
Journal:  Hepatol Int       Date:  2019-11-08       Impact factor: 6.047

2.  Hydrogen sulfide and nonalcoholic fatty liver disease.

Authors:  Panzhi Wang; Liming Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

3.  Relative skeletal muscle mass and non-alcoholic fatty liver disease: from association to causation.

Authors:  Hee Yeon Kim; Jong Young Choi; Yong-Moon Park
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

4.  Fatty Liver Index and Skeletal Muscle Density.

Authors:  Julie A Pasco; Sophia X Sui; Emma C West; Kara B Anderson; Pamela Rufus-Membere; Monica C Tembo; Natalie K Hyde; Lana J Williams; Zoe S J Liu; Mark A Kotowicz
Journal:  Calcif Tissue Int       Date:  2022-01-13       Impact factor: 4.000

5.  Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.

Authors:  Cristiane V Tovo; Sabrina A Fernandes; Caroline Buss; Angelo A de Mattos
Journal:  World J Hepatol       Date:  2017-02-28

Review 6.  Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.

Authors:  Eleonora Poggiogalle; Lorenzo Maria Donini; Andrea Lenzi; Claudio Chiesa; Lucia Pacifico
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

7.  The Relationship between NAFLD and Sarcopenia in Elderly Patients.

Authors:  Yu Zhai; Qian Xiao; Jing Miao
Journal:  Can J Gastroenterol Hepatol       Date:  2018-03-26

Review 8.  Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.

Authors:  Rui Yu; Qiangwei Shi; Lei Liu; Lidong Chen
Journal:  BMC Gastroenterol       Date:  2018-04-19       Impact factor: 3.067

Review 9.  The Common Mechanisms of Sarcopenia and NAFLD.

Authors:  Yu Zhai; Qian Xiao
Journal:  Biomed Res Int       Date:  2017-12-13       Impact factor: 3.411

10.  Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38).

Authors:  Goh Eun Chung; Ji Won Yoon
Journal:  J Obes Metab Syndr       Date:  2020-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.